Patent Yard Sign in
Canadian application, no grantCanada

Medicine for the treatment of tumor

CA 2134194 A1 · Owner: Oguro, Masao · Inventors: Oguro, Masao

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

of Disclosure, A medicine for the treatment of tumor. The medicine contains 4-piperidino-piperidine or a physiologically acceptable salt thereof as the effective component. Although 4-piperidino-piperidine or a physiologically acceptable salt thereof do not exhibit tumor cell killing effect per se, they suppress propagation of tumor cells dissolve resistance of other antitumor drugs and enhance, the antitumor activity of antitumor drugs. Therefore when, the medicine according to the present invention is used in combination with other antitumor drugs their inherent, antitumor activity is enhanced. Since the dose of antitumor drugs which are to be used along with the medicine of the present …

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed October 24, 1994. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 24, 2014.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 24, 2016.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledOctober 24, 1994
GrantedNo grant recorded
Term endedOctober 24, 2014
Patent numberCA 2134194 A1
Classification (IPC)A61K33/24 +2 more

Timeline

Timeline From CIPO dates

1995199719992001200320052007200920112013Application filedOct 24, 1994Term endedOct 24, 2014

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.